Daniele Pezzati
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Daniele Pezzati has a total of 128 co-authors. Here are the top co-authors by number of shared publications:
- Davide Ghinolfi
Division of Hepatic Surgery and Liver Transplantation, University Hospital of Pisa, Pisa, Italy
12 shared publications Franco Filipponi
10 shared publicationsPaolo De Simone
9 shared publications- Quirino Lai
General Surgery and Organ Transplantation Unit, Sapienza University, AOU Policlinico Umberto I, Rome, Italy
5 shared publications F. Filipponi
Hepatobiliary Surgery and Liver Transplantation Unit, University of Pisa Medical School Hospital, Pisa, Italy
4 shared publicationsGiulia Cirillo
Hepatobiliary Surgery and Liver Transplantation Unit, University of Pisa Medical School Hospital, Pisa, Italy
4 shared publications
Latest Publications
- 26 October 2026
- Published by Wolters Kluwer Health in Liver Transplantation
A randomized controlled trial of normothermic versus dual-hypothermic oxygenated ex situ perfusion in DCD liver transplantation
DCD (donation after circulatory death) liver transplantation has expanded worldwide but remains associated with an increased risk of complications. Sequential use of normothermic regional perfusion (NRP) followed by ex situ machine perfusion (MP) is increasingly adopted, but the choice of MP technique remains controversial. This randomized controlled trial compares outcomes of dual-hypothermic oxygenated perfusion (D-HOPE) versus normothermic machine perfusion (NMP) following NRP in DCD liver transplantation. After NRP, 50 grafts (44 controlled and 6 uncontrolled DCD) were randomized 1:1 to D-HOPE or NMP using concealed allocation with sequentially numbered sealed envelopes. Ex situ perfusion was not performed for additional assessment. The primary endpoint was 1-year incidence of serious adverse events (SAEs), including graft or patient loss and biliary or vascular complications. Secondary endpoints included other perioperative outcomes. We have also performed an exploratory analysis to identify predictive factors of graft loss and SAEs. No case of primary nonfunction or vascular complication occurred. One-year graft and patient survival were both 88% in the D-HOPE group and 100% in the NMP group ( p =0.07). One-year SAE rate was similar (16% vs. 20%, p =0.31). Biliary leakage and postoperative dialysis rate were comparable between the 2 groups (16% vs. 0%, p =0.12). Blood pH variation, lactate and IL-6 levels during NRP, perfusate lactate trend, portal flow, IL-6, IL-10 and TNF levels during D-HOPE, and perfusate pH variations and IL-10 levels during NMP were related to graft loss. When applied after NRP, D-HOPE and NMP provide comparable mid-term clinical outcomes in DCD liver transplantation. Differences in specific complications may require individualized selection of ex situ MP. The limited sample size and number of events preclude definitive conclusions regarding differences in individual complications or the relative efficacy of either ex situ perfusion strategy. The observed differences in specific complications and exploratory associations with perfusion parameters warrant evaluation in larger prospective studies.
- 26 October 2026
- Published by Wolters Kluwer Health in Liver Transplantation
A randomized controlled trial of normothermic versus dual-hypothermic oxygenated ex situ perfusion in DCD liver transplantation
DCD (donation after circulatory death) liver transplantation has expanded worldwide but remains associated with an increased risk of complications. Sequential use of normothermic regional perfusion (NRP) followed by ex situ machine perfusion (MP) is increasingly adopted, but the choice of MP technique remains controversial. This randomized controlled trial compares outcomes of dual-hypothermic oxygenated perfusion (D-HOPE) versus normothermic machine perfusion (NMP) following NRP in DCD liver transplantation. After NRP, 50 grafts (44 controlled and 6 uncontrolled DCD) were randomized 1:1 to D-HOPE or NMP using concealed allocation with sequentially numbered sealed envelopes. Ex situ perfusion was not performed for additional assessment. The primary endpoint was 1-year incidence of serious adverse events (SAEs), including graft or patient loss and biliary or vascular complications. Secondary endpoints included other perioperative outcomes. We have also performed an exploratory analysis to identify predictive factors of graft loss and SAEs. No case of primary nonfunction or vascular complication occurred. One-year graft and patient survival were both 88% in the D-HOPE group and 100% in the NMP group ( p =0.07). One-year SAE rate was similar (16% vs. 20%, p =0.31). Biliary leakage and postoperative dialysis rate were comparable between the 2 groups (16% vs. 0%, p =0.12). Blood pH variation, lactate and IL-6 levels during NRP, perfusate lactate trend, portal flow, IL-6, IL-10 and TNF levels during D-HOPE, and perfusate pH variations and IL-10 levels during NMP were related to graft loss. When applied after NRP, D-HOPE and NMP provide comparable mid-term clinical outcomes in DCD liver transplantation. Differences in specific complications may require individualized selection of ex situ MP. The limited sample size and number of events preclude definitive conclusions regarding differences in individual complications or the relative efficacy of either ex situ perfusion strategy. The observed differences in specific complications and exploratory associations with perfusion parameters warrant evaluation in larger prospective studies.
- 18 September 2024
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 31 (1) , 70-84
Are there any benefits of prolonged hypothermic oxygenated perfusion?: Results from a national retrospective study
Dual hypothermic oxygenated perfusion (DHOPE) is increasingly being used to extend liver preservation to improve transplant logistics. However, little is known about its benefits in high-risk liver grafts. This study aimed to investigate whether prolonged DHOPE provides benefits other than improved logistics in all liver types. We performed a national retrospective cohort study of 177 liver transplants from 12 Italian centers preserved with DHOPE for ≥4 hours between 2015 and 2022. A control group of 177 DHOPEs of p= 0.008). Among prolonged DHOPEs, no differences in transplant outcomes were observed according to donor risk index, Eurotransplant definition for marginal grafts, and balance of risk score. DHOPE duration was associated with a lower risk of AKI in multivariable models adjusted for donor risk index, Eutrotransplant marginal grafts, and balance of risk score. Prolonged hypothermic oxygenated perfusion confirmed its protective effect against AKI in a multivariable model adjusted for donor and recipient risk factors [OR: 0.412, 95% CI: 0.200–0.850,p= 0.016]. Prolonged DHOPE is widely used to improve transplant logistics, provides good results with high-risk grafts, and appears to be associated with a lower risk of posttransplant AKI. These results provide further insight into the important role of DHOPE in preventing posttransplant complications.
- 18 September 2024
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 31 (1) , 70-84
Are there any benefits of prolonged hypothermic oxygenated perfusion?: Results from a national retrospective study
Dual hypothermic oxygenated perfusion (DHOPE) is increasingly being used to extend liver preservation to improve transplant logistics. However, little is known about its benefits in high-risk liver grafts. This study aimed to investigate whether prolonged DHOPE provides benefits other than improved logistics in all liver types. We performed a national retrospective cohort study of 177 liver transplants from 12 Italian centers preserved with DHOPE for ≥4 hours between 2015 and 2022. A control group of 177 DHOPEs of p= 0.008). Among prolonged DHOPEs, no differences in transplant outcomes were observed according to donor risk index, Eurotransplant definition for marginal grafts, and balance of risk score. DHOPE duration was associated with a lower risk of AKI in multivariable models adjusted for donor risk index, Eutrotransplant marginal grafts, and balance of risk score. Prolonged hypothermic oxygenated perfusion confirmed its protective effect against AKI in a multivariable model adjusted for donor and recipient risk factors [OR: 0.412, 95% CI: 0.200–0.850,p= 0.016]. Prolonged DHOPE is widely used to improve transplant logistics, provides good results with high-risk grafts, and appears to be associated with a lower risk of posttransplant AKI. These results provide further insight into the important role of DHOPE in preventing posttransplant complications.
- 1 August 2018
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 268 (2) , 325-331
Use of Elderly Donors in Liver Transplantation
Objective: To evaluate the use of elderly donors in liver transplantation (LT) and identify risk factors associated with a worse outcome. Summary Background Data: Use of livers from very old donors could expand the donor pool but is not universally implemented. Methods: This is a retrospective, single-center medical record review. From January 2001 to December 2014, 1354 LTs were performed. After exclusion of donors P = 0.3), HCV-related death (7.6 vs. 8.7%; P = 0.6), vascular (5.8 vs. 5.0%; P = 0.7), and biliary complications (16.5 vs. 18.6%; P = 0.4). On multivariate analysis, independent risk factors for graft loss were: HCV-positive recipient (HR = 2.1; 95% CI = 1.6–2.7; P < 0.001), donor age (HR = 1.0; 95% CI = 1.0–1.0; P < 0.001), cold ischemia time (HR = 1.0; 95% CI = 1.0–1.0; P = 0.042), and donor history of diabetes mellitus (HR = 1.48; 95% CI = 1.03–2.13; P = 0.036). Conclusions: Use of elderly donors is not associated per se with an increased risk of vascular and biliary complications. In the presence of cold ischemia time and diabetes mellitus, appropriate donor-to-recipient matching is warranted.
- 1 August 2018
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 268 (2) , 325-331
Use of Elderly Donors in Liver Transplantation
Objective: To evaluate the use of elderly donors in liver transplantation (LT) and identify risk factors associated with a worse outcome. Summary Background Data: Use of livers from very old donors could expand the donor pool but is not universally implemented. Methods: This is a retrospective, single-center medical record review. From January 2001 to December 2014, 1354 LTs were performed. After exclusion of donors P = 0.3), HCV-related death (7.6 vs. 8.7%; P = 0.6), vascular (5.8 vs. 5.0%; P = 0.7), and biliary complications (16.5 vs. 18.6%; P = 0.4). On multivariate analysis, independent risk factors for graft loss were: HCV-positive recipient (HR = 2.1; 95% CI = 1.6–2.7; P < 0.001), donor age (HR = 1.0; 95% CI = 1.0–1.0; P < 0.001), cold ischemia time (HR = 1.0; 95% CI = 1.0–1.0; P = 0.042), and donor history of diabetes mellitus (HR = 1.48; 95% CI = 1.03–2.13; P = 0.036). Conclusions: Use of elderly donors is not associated per se with an increased risk of vascular and biliary complications. In the presence of cold ischemia time and diabetes mellitus, appropriate donor-to-recipient matching is warranted.
- 6 January 2018
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 24 (4) , 557-561
Ex situ 86‐hour liver perfusion: Pushing the boundary of organ preservation
- 6 January 2018
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 24 (4) , 557-561
Ex situ 86‐hour liver perfusion: Pushing the boundary of organ preservation
- 10 November 2017
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 24 (2) , 233-245
Lipid metabolism and functional assessment of discarded human livers with steatosis undergoing 24 hours of normothermic machine perfusion
Normothermic machine perfusion (NMP) is an emerging technology to preserve liver allografts more effectively than cold storage (CS). However, little is known about the effect of NMP on steatosis and the markers indicative of hepatic quality during NMP. To address these points, we perfused 10 discarded human livers with oxygenated NMP for 24 hours after 4‐6 hours of CS. All livers had a variable degree of steatosis at baseline. The perfusate consisted of packed red blood cells and fresh frozen plasma. Perfusate analysis showed an increase in triglyceride levels from the 1st hour (median, 127 mg/dL; interquartile range [IQR], 95‐149 mg/dL) to 24th hour of perfusion (median, 203 mg/dL; IQR, 171‐304 mg/dL; P = 0.004), but tissue steatosis did not decrease. Five livers produced a significant amount of bile (≥5 mL/hour) consistently throughout 24 hours of NMP. Lactate in the perfusate cleared to Liver Transplantation 24 233–245 2018 AASLD.
- 10 November 2017
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 24 (2) , 233-245
Lipid metabolism and functional assessment of discarded human livers with steatosis undergoing 24 hours of normothermic machine perfusion
Normothermic machine perfusion (NMP) is an emerging technology to preserve liver allografts more effectively than cold storage (CS). However, little is known about the effect of NMP on steatosis and the markers indicative of hepatic quality during NMP. To address these points, we perfused 10 discarded human livers with oxygenated NMP for 24 hours after 4‐6 hours of CS. All livers had a variable degree of steatosis at baseline. The perfusate consisted of packed red blood cells and fresh frozen plasma. Perfusate analysis showed an increase in triglyceride levels from the 1st hour (median, 127 mg/dL; interquartile range [IQR], 95‐149 mg/dL) to 24th hour of perfusion (median, 203 mg/dL; IQR, 171‐304 mg/dL; P = 0.004), but tissue steatosis did not decrease. Five livers produced a significant amount of bile (≥5 mL/hour) consistently throughout 24 hours of NMP. Lactate in the perfusate cleared to Liver Transplantation 24 233–245 2018 AASLD.
- 23 August 2017
- Published by Frontiers Media SA in Transplant International
- Vol. 30 (11) , 1190-1191
Liver transplantation with geriatric liver allograft in the US: a matter of epidemiology or outcome requirements?
We read with interest the letter "Liver transplantation with geriatric liver allografts: the current situation in Eurotransplant" by De Boer et al as it analyzes important aspects in the utilization of "older" donor allografts (1). In this communication we would like to discuss how the utilization of elderly donors (≥70 years old) in the United States differs from that of Europe, offer potential explanations for these different utilization pattern and suggest a potential intervention which could function to systematically enhance older liver donor transplantation in the United States. This article is protected by copyright. All rights reserved.
- 23 August 2017
- Published by Frontiers Media SA in Transplant International
- Vol. 30 (11) , 1190-1191
Liver transplantation with geriatric liver allograft in the US: a matter of epidemiology or outcome requirements?
We read with interest the letter "Liver transplantation with geriatric liver allografts: the current situation in Eurotransplant" by De Boer et al as it analyzes important aspects in the utilization of "older" donor allografts (1). In this communication we would like to discuss how the utilization of elderly donors (≥70 years old) in the United States differs from that of Europe, offer potential explanations for these different utilization pattern and suggest a potential intervention which could function to systematically enhance older liver donor transplantation in the United States. This article is protected by copyright. All rights reserved.
- Open Access
- 1 July 2017
- Published by Elsevier in American Journal of Transplantation
- Vol. 17 (7) , 1956-1957
Normothermic Machine Perfusion: A New World Deserving Careful Exploration
- 1 July 2017
- Published by Elsevier in American Journal of Transplantation
- Vol. 17 (7) , 1956-1957
Open AccessNormothermic Machine Perfusion: A New World Deserving Careful Exploration
- 22 May 2017
- Published by Frontiers Media SA in Transplant International
- Vol. 30 (7) , 737-739
Use of donors with genitourinary malignancies for liver transplantation: a calculated risk?
- 22 May 2017
- Published by Frontiers Media SA in Transplant International
- Vol. 30 (7) , 737-739
Use of donors with genitourinary malignancies for liver transplantation: a calculated risk?
- 1 May 2017
- Published by Elsevier in Transplantation Proceedings
- Vol. 49 (4) , 726-728
Salvage of an Octogenarian Liver Graft Using Normothermic Perfusion: A Case Report
- 1 May 2017
- Published by Elsevier in Transplantation Proceedings
- Vol. 49 (4) , 726-728
Salvage of an Octogenarian Liver Graft Using Normothermic Perfusion: A Case Report
- Open Access
- 24 November 2016
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 23 (5) , 707-708
Anti‐inflammatory signaling during ex vivo liver perfusion improves the preservation of pig liver grafts before transplantation
- 24 November 2016
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 23 (5) , 707-708
Open AccessAnti‐inflammatory signaling during ex vivo liver perfusion improves the preservation of pig liver grafts before transplantation